GenBioPro Inc. v. Raynes et al.

Why this Matters:

The Plaintiff alleges that West Virginia’s abortion ban, which effectively bans the sale of mifepristone in the state, conflicts with the Food and Drug Administration’s (FDA’s) federal approval of the drug. In this appeal, the Plaintiff alleges that the district court erred in finding that federal law does not override West Virginia’s restrictions on mifepristone.  

Potential Impact:

Overriding the FDA’s expertise and preventing individuals from accessing effective medication for abortion services will jeopardize their health and safety.